Molecular Partners AG

LSE:0QXX Stock Report

Market Cap: CHF 163.3m

Molecular Partners Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0QXX?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,632,6864.43%
Public Companies1,739,1304.72%
General Public2,794,9837.58%
Institutions4,379,29111.9%
Hedge Funds26,317,00571.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.2%.

Top Shareholders

Top 25 shareholders own 92.38% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
53.1%
BVF Partners L.P.
19,583,011CHF 86.8m125%2.8%
12.7%
Suvretta Capital Management, LLC
4,684,806CHF 20.8m168%0.78%
5.56%
EcoR1 Capital, LLC
2,049,188CHF 9.1m0%0.32%
5.24%
UBS Asset Management AG
1,932,920CHF 8.6m0.09%no data
4.72%
Novartis AG
1,739,130CHF 7.7m0%no data
2.79%
GAM Holding AG
1,027,810CHF 4.6m0%0.06%
2.08%
Michael Stumpp
767,524CHF 3.4m0%no data
1.99%
Patrick Amstutz
735,095CHF 3.3m0%no data
1.15%
Union Bancaire Privee, CBI-TDB, Asset Management Arm
425,615CHF 1.9m0.04%0.04%
0.59%
ZKB Asset Management
217,950CHF 965.5k28.4%no data
0.54%
Acatis Anlageberatung fur Investmentfonds GmbH
200,000CHF 886.0k0%0.06%
0.34%
Fourton Fund Management Co. Ltd
123,946CHF 549.1k0%0.21%
0.33%
Zürcher Kantonalbank, Investment Arm
122,369CHF 542.1k0%no data
0.28%
Pictet Asset Management SA
103,843CHF 460.0k2.66%no data
0.22%
BlackRock, Inc.
80,825CHF 358.1k1.62%no data
0.19%
BCV Asset Management
70,000CHF 310.1k0%0.01%
0.11%
Migrosbank Asset Management
41,529CHF 184.0k0%0.01%
0.079%
Nicolas Leupin
29,168CHF 129.2k0%no data
0.073%
William A. Burns
26,951CHF 119.4k0%no data
0.07%
Alexander Zurcher
25,706CHF 113.9k0%no data
0.062%
Renate Gloggner
23,006CHF 101.9k0%no data
0.04%
Steven H. Holtzman
14,717CHF 65.2k0%no data
0.035%
Baloise Asset Management
12,798CHF 56.7k-9.36%no data
0.032%
Dimensional Fund Advisors LP
11,788CHF 52.2k0.24%no data
0.014%
Tolomeo Capital AG
5,114CHF 22.7k-4.23%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 03:23
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Molecular Partners AG is covered by 14 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Maurizio BernasconiBank am Bellevue
null nullCredit Suisse
Thomas KaufmannCredit Suisse